Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122299
Filing Date
2024-11-06
Accepted
2024-11-06 16:10:22
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q allk-20240930.htm   iXBRL 10-Q 1644283
2 EX-31.1 allk-ex31_1.htm EX-31.1 17055
3 EX-31.2 allk-ex31_2.htm EX-31.2 17078
4 EX-32.1 allk-ex32_1.htm EX-32.1 9185
5 EX-32.2 allk-ex32_2.htm EX-32.2 9206
  Complete submission text file 0000950170-24-122299.txt   7036093

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT allk-20240930.xsd EX-101.SCH 900048
67 EXTRACTED XBRL INSTANCE DOCUMENT allk-20240930_htm.xml XML 1343968
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38582 | Film No.: 241431016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)